Why the study?
Does specific treatment of primary aldosteronism improve diurnal blood pressure variability in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism?
Does specific treatment of primary aldosteronism improve diurnal blood pressure variability in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism?
Primary aldosteronism is associated with a blunted nocturnal blood pressure fall that can be normalized with specific surgical or medical therapy.
Answers are grounded in this paper and cite their sources.
Targeted therapy may normalize nocturnal BP dipping in primary aldosteronism; hypothesis-generating for CV outcomes, pending randomized confirmation.
The aim of our study was to evaluate the potential differences in blood pressure (BP) profile in subjects with different forms of primary aldosteronism (PA). Simultaneously, we studied the effects of PA treatment on BP curve. We therefore monitored 24-hour ambulatory blood pressure values in 22 subjects with aldosterone-producing adenoma (APA), 22 subjects with idiopathic hyperaldosteronism (IHA) and 33 subjects with essential hypertension (EH) as controls. We found a significantly attenuated nighttime systolic BP decline in the APA group (P=0.02). Patients with IHA had lower nighttime systolic BP values (P=0.01) and also a diastolic BP decline (P=0.02) during the night in comparison with EH. We did not detect any significant differences in BP profile characteristics between APA and IHA. Specific treatment of primary aldosteronism (adrenalectomy, treatment with spironolactone) led to the normalization of the BP curve with a marked BP decline. Our study thus demonstrates a blunted diurnal BP variability in patients with primary aldosteronism the specific treatment of which normalized previously attenuated nocturnal BP fall.
No takes yet. Share an insight, caveat, or question.
Zelinka et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: